OpGen, Inc. (NASDAQ: OPGN) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
Last opgen, inc earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: ir.opgen.com
| Impact snapshot | Event time: | OPGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
OPGN alerts
OPGN alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPGN alerts
High impacting OpGen, Inc news events
Weekly update
A roundup of the hottest topics
OPGN
News
- OpGen shares surge 16% premarket on rapid panel test for COVID-19 patients [Seeking Alpha]Seeking Alpha
- OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 PneumoniaGlobeNewswire
- OpGen, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/OPGN/price-target/">NASDAQ: OPGN</a>) had its price target raised by analysts at Alliance Global Partners from $5.65 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- OpGen shares gain 17% on Chinese approval of Curetis Unyvero System [Seeking Alpha]Seeking Alpha
- OpGen Wins Chinese NMPA Approval for the Curetis Unyvero SystemGlobeNewswire
- More
OPGN
SEC Filings
- 3/8/21 - Form 8-K
- 3/5/21 - Form 4
- 3/5/21 - Form 4
- OPGN's page on the SEC website
- More